Melvin LK Chua, Head of the Department of Head Neck and Thoracic Cancers, Division of Radiation Oncology at National Cancer Centre Singapore, shared a post on X:
“Another interesting trial in Head Neck Cancer.
Phase 3 RCT from Singapore presented by Gopal Iyer, led by our centre Founding Director Prof Soo KC.
Likewise, to ComPARE some signal in specific subsets, such as Oral Cavity vs. others.
Perhaps RCTs in HN should be targeted to anatomic sites.”
More posts featuring Melvin LK Chua on OncoDaily.
